Table 1.
Baseline characteristics of study patients.
| Number of eyes | 30 eyes of 23 patients |
|---|---|
| Demographics factors | Mean ± SD or N (%) |
| Age (years) | 60.70 ± 9.28 |
| Sex, male | 19 (63.33) |
| Female | 11 (36.66) |
| DM duration (years) | 14.33 ± 8.73 |
| HbA1C (%) | 6.93 ± 1.52 |
| Medication, insulin | 4 (13.33) |
| OHA | 26 (86.66) |
|
| |
| Ocular factors | |
| DMR severity | |
| NPDR | 18 (60.00) |
| PDR | 12 (40.00) |
| Previous treatment history | |
| Vitrectomy+PRP | 4 (13.33) |
| Bevacizumab+PRP | 5 (16.66) |
| Bevacizumab only | 5 (16.66) |
| PRP only | 8 (26.66) |
| Treatment-naïve | 8 (26.66) |
SD: standard deviation; N: number; DM: diabetes mellitus; HbA1c: glycated hemoglobin; OHA: oral hypoglycemic agents; DMR: diabetic retinopathy; (N)PDR: (non)proliferative diabetic retinopathy; PRP: panretinal photocoagulation.